Filing Details

Accession Number:
0001415889-24-029920
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-19 18:50:31
Reporting Period:
2024-12-17
Accepted Time:
2024-12-19 18:50:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851194 Ventyx Biosciences Inc. VTYX Pharmaceutical Preparations (2834) 832996852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1874108 John Nuss C/O Ventyx Biosciences, Inc.
12790 El Camino Real, Suite 200
San Diego CA 92130
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-17 34,930 $0.00 498,862 No 4 M Direct
Common Stock Disposition 2024-12-19 13,161 $2.26 485,701 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2024-12-17 34,930 $0.00 34,930 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,930 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
  2. Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  3. Represents the weighted average share price of an aggregate total of 13,161 shares sold in the price range of $2.205 to $2.38. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.